Loading…

Ypsomed opened a new production hall (Hall D) at its Schwerin site, investing 22 million CHF. The company also announced a further expansion (Schwerin II) starting January 2025, with a total investment of nearly half a billion Swiss francs, to add 400-500 million pens and autoinjectors annual capacity.
“The expansion of our Schwerin site is an important step in our growth strategy, which will enable us to increase our production capacity and expand further in the coming years.”ypsomed.com
Summarized from public sources; check the original articles before acting on it.